Interestingly, these two studies are seemingly opposite to findings from Zeggar et al., who using a pristane-induced lupus model, observed that LGALS9–/– mice exhibited reduced disease burden and unaltered TLR7-type I interferon signaling (72). Here, LGALS9 is linked to systemic lupus erythematosus.